Deferasirox 69539-0022
Product NDC
69539-0022- Manufacturer
- Msn Laboratories Private Limited
- Dosage Form
- Tablet, For Suspension
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- November 20, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA209878
Need to source Deferasirox? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Deferasirox | 250 mg/1 |
Drug Class
Iron Chelator [EPC]Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]
Packaging Options(4)
10 BLISTER PACK in 1 CARTON (69539-022-06) / 10 TABLET, FOR SUSPENSION in 1 BLISTER PACK (69539-022-11)
30 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-022-30)
90 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-022-90)
1000 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-022-99)